11 results

S1 Changing landscape of diagnosis and treatment of bladder cancer
Wun-Jae Kim
KMSID: 1088101   Investig Clin Urol. 2016;57(Suppl 1):S1-S3.   Published online 2016 June 10    DOI: http://dx.doi.org/10.4111/icu.2016.57.S1.S1
      
S4 Active surveillance for nonmuscle invasive bladder cancer
Makito Miyake, Kiyohide Fujimoto, Yoshihiko Hirao
KMSID: 1088114   Investig Clin Urol. 2016;57(Suppl 1):S4-S13.   Published online 2016 May 27    DOI: http://dx.doi.org/10.4111/icu.2016.57.S1.S4
      
S14 Dietary factors associated with bladder cancer
Chandrika Piyathilake
KMSID: 1088107   Investig Clin Urol. 2016;57(Suppl 1):S14-S25.   Published online 2016 June 10    DOI: http://dx.doi.org/10.4111/icu.2016.57.S1.S14
      
S26 Treatment of bladder cancer in the elderly
Annette Erlich, Alexandre R. Zlotta
KMSID: 1088112   Investig Clin Urol. 2016;57(Suppl 1):S26-S35.   Published online 2016 May 27    DOI: http://dx.doi.org/10.4111/icu.2016.57.S1.S26
      
S36 Open versus robotic cystectomy: Comparison of outcomes
Rachel B. Davis, Nicholas J. Farber, Alexandra L. Tabakin, Isaac Y. Kim, Sammy E. Elsamra
KMSID: 1088113   Investig Clin Urol. 2016;57(Suppl 1):S36-S43.   Published online 2016 June 10    DOI: http://dx.doi.org/10.4111/icu.2016.57.S1.S36
      
S44 How do we manage high-grade T1 bladder cancer? Conservative or aggressive therapy?
Seok Joong Yun, Seon-Kyu Kim, Wun-Jae Kim
KMSID: 1088115   Investig Clin Urol. 2016;57(Suppl 1):S44-S51.   Published online 2016 June 10    DOI: http://dx.doi.org/10.4111/icu.2016.57.S1.S44
      
S52 Aberrantly expressed microRNAs in the context of bladder tumorigenesis
Jong-Young Lee, Dong-Sung Ryu, Wun-Jae Kim, Seong-Jin Kim
KMSID: 1088116   Investig Clin Urol. 2016;57(Suppl 1):S52-S59.   Published online 2016 June 10    DOI: http://dx.doi.org/10.4111/icu.2016.57.S1.S52
      
S60 The role of microRNAs in bladder cancer
Hideki Enokida, Hirofumi Yoshino, Ryosuke Matsushita, Masayuki Nakagawa
KMSID: 1088117   Investig Clin Urol. 2016;57(Suppl 1):S60-S76.   Published online 2016 June 7    DOI: http://dx.doi.org/10.4111/icu.2016.57.S1.S60
      
S77 Can we use methylation markers as diagnostic and prognostic indicators for bladder cancer?
Yong-June Kim, Wun-Jae Kim
KMSID: 1088118   Investig Clin Urol. 2016;57(Suppl 1):S77-S88.   Published online 2016 May 25    DOI: http://dx.doi.org/10.4111/icu.2016.57.S1.S77
      
S89 Autophagy and urothelial carcinoma of the bladder: A review
Thenappan Chandrasekar, Christopher P. Evans
KMSID: 1088119   Investig Clin Urol. 2016;57(Suppl 1):S89-S97.   Published online 2016 June 10    DOI: http://dx.doi.org/10.4111/icu.2016.57.S1.S89
      
S98 Immune checkpoint blockade therapy for bladder cancer treatment
Jayoung Kim
KMSID: 1088120   Investig Clin Urol. 2016;57(Suppl 1):S98-S105.   Published online 2016 May 26    DOI: http://dx.doi.org/10.4111/icu.2016.57.S1.S98
      
Articles from Investigative and Clinical Urology are provided here courtesy of The Korean Urological Association